跳到正文
原文
Science Magazine· @ScienceMagazine · X·· 12 天前AI 评分20
AI 导读

GLP-1受体激动剂是肥胖及其他代谢疾病最有效的治疗手段之一,广泛使用后已明确其作用远超传统代谢相关疾病,还影响多个其他器官系统,尤其是大脑。该领域研究也已不再局限于GL-1受体这一靶点,正在开发更多药物及联合方案以优化患者治疗。详见Science专刊。

正文

GLP-1 receptor agonists are among the most effective treatments for obesity and other metabolic disorders. With widespread use of these drugs, it has become clear that their effects go well beyond health conditions traditionally linked to metabolism, affecting multiple other organ systems, particularly the brain.

Continued research in this field has also expanded beyond the GLP-1 receptor as a target, with the development of additional drugs and combinations to help optimize patient care.

Learn more in this special issue of Science: https://scim.ag/4yX17UB

来源:Science Magazine · x.com